Information  X 
Enter a valid email address

SYNCONA (SYNC)

Date Time Source Announcement
06 Jan 2021 7:00 am
RNS
Autolus Business Outlook
21 Dec 2020 7:00 am
RNS
Virginia Holmes Appointed Non-Executive Director
14 Dec 2020 12:05 pm
RNS
Freeline reports updated clinical data
07 Dec 2020 5:05 pm
RNS
Autolus presents additional data on AUTO3
  7:05 am
RNS
Autolus presents additional data on AUTO1
27 Nov 2020 4:35 pm
RNS
Price Monitoring Extension
19 Nov 2020 7:00 am
RNS
Half-year Report
  7:00 am
RNS
Syncona founds Purespring with a �45m Series A
05 Nov 2020 12:11 pm
RNS
Autolus reports Q3 2020 Financial Results
03 Nov 2020 8:30 am
RNS
Notice of Results
02 Nov 2020 7:00 am
RNS
Directorate Change
30 Oct 2020 7:00 am
RNS
Freeline H1 Results and Business Highlights
18 Sep 2020 8:10 am
RNS
Autolus presents additional data on AUTO3
14 Sep 2020 1:05 pm
RNS
Syncona expands cell therapy portfolio
07 Sep 2020 12:07 pm
RNS
Second Price Monitoring Extn
  12:02 pm
RNS
Price Monitoring Extension
10 Aug 2020 7:00 am
RNS
Quarterly Update
07 Aug 2020 7:00 am
RNS
Freeline update on IPO
06 Aug 2020 12:10 pm
RNS
Autolus reports Q2 2020 Financial Results
03 Aug 2020 11:30 am
RNS
Update on Freeline proposed IPO in the U.S.
28 Jul 2020 12:00 pm
RNS
Result of AGM
20 Jul 2020 7:00 am
RNS
Freeline files registration statement
13 Jul 2020 4:51 pm
RNS
Freeline publishes further data for FLT180a
09 Jul 2020 1:00 pm
RNS
Issue of shares pursuant to Incentive Scheme
30 Jun 2020 7:00 am
RNS
Freeline announces additional financing plans
  7:00 am
RNS
Freeline expands Series C financing to $120million
25 Jun 2020 12:38 pm
RNS
Annual Financial Report
18 Jun 2020 12:45 pm
RNS
Director/PDMR Shareholding
15 Jun 2020 7:00 am
RNS
Kemal Malik Appointed as Non-Executive Director
12 Jun 2020 7:36 am
RNS
Autolus AUTO1 and AUTO3 data at EHA
11 Jun 2020 7:00 am
RNS
Final Results
29 May 2020 12:49 pm
RNS
Autolus presents additional data on AUTO3 in DLBCL
  7:05 am
RNS
First patient dosed in Achilles' melanoma study
20 May 2020 9:24 am
RNS
Notice of Results
07 May 2020 12:15 pm
RNS
Autolus reports Q1 2020 Financial Results
23 Apr 2020 7:00 am
RNS
New commitment to SwanBio
16 Apr 2020 12:10 pm
RNS
Autolus announces acceptance of IND application
31 Mar 2020 1:26 pm
RNS
Director/PDMR Shareholding
26 Mar 2020 9:41 am
RNS
Standard form for notification of major holdings
23 Mar 2020 7:00 am
RNS
Business Update
20 Mar 2020 4:44 pm
RNS
Second Price Monitoring Extn
  4:39 pm
RNS
Price Monitoring Extension
  1:53 pm
RNS
Director/PDMR Shareholding
05 Mar 2020 11:14 am
RNS
Director/PDMR Shareholding
03 Mar 2020 12:29 pm
RNS
Autolus reports Q4 2019 Financial Results
12 Feb 2020 2:00 pm
RNS
Freeline presents clinical data at WORLDSymposium
07 Feb 2020 1:24 pm
RNS
Freeline publishes further data for FLT180a
04 Feb 2020 7:00 am
RNS
Quarterly Update
30 Jan 2020 12:08 pm
RNS
Autolus announces additional data in AUTO3 at EHA
23 Jan 2020 7:00 am
RNS
Autolus announces pricing of public offering
21 Jan 2020 12:01 pm
RNS
Freeline to present further FLT180a data at EAHAD
  8:45 am
RNS
Notice of Capital Markets Day
19 Dec 2019 7:00 am
RNS
Syncona makes further $80m commitment to Freeline
09 Dec 2019 7:00 am
RNS
Autolus announces new data in AUTO3 at ASH
  7:00 am
RNS
Autolus announces new data at ASH Annual Meeting
21 Nov 2019 7:00 am
RNS
Syncona leads �32 million financing in Azeria
  7:00 am
RNS
Interim Results
11 Nov 2019 9:00 am
RNS
Notice of Results
07 Nov 2019 12:32 pm
RNS
Autolus reports Q3 2019 Financial Results
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t